Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%

被引：24

作者：

Bellini, V. ^{[1
]}

Simonetti, S. ^{[1
]}

Lisi, P. ^{[1
]}

机构：

[1] Univ Perugia, Clin Allergol & Venereol Dermatol Unit, Dept Med & Surg Special & Publ Hlth, I-06122 Perugia, Italy

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2008年 / 22卷 / 01期

关键词：

D O I：

10.1111/j.1468-3083.2007.02280.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：113 / 115

页数：5

共 10 条

[1] Percutaneous absorption of drugs used in atopic eczema:: pimecrolimus permeates less through skin than corticosteroids and tacrolimus [J].

Billich, A ;

Aschauer, H ;

Aszódi, A ;

Stuetz, A .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) :29-35

[2] Topical tacrolimus therapy for pyoderma gangrenosum [J].

Chiba, T ;

Isomura, I ;

Suzuki, A ;

Morita, A .

JOURNAL OF DERMATOLOGY, 2005, 32 (03) :199-203

[3] TUMOR-NECROSIS-FACTOR-ALPHA IS PRO-INFLAMMATORY IN NORMAL HUMAN SKIN AND MODULATES CUTANEOUS ADHESION MOLECULE EXPRESSION [J].

GROVES, RW ;

ALLEN, MH ;

ROSS, EL ;

BARKER, JNWN ;

MACDONALD, DM .

BRITISH JOURNAL OF DERMATOLOGY, 1995, 132 (03) :345-352

[4] Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells [J].

Hoetzenecker, W ;

Meingassner, JG ;

Ecker, R ;

Stingl, G ;

Stuetz, A ;

Elbe-Bürger, A .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) :673-684

[5] PYODERMA GANGRENOSUM, ALTERED DELAYED-HYPERSENSITIVITY, AND POLYARTHRITIS [J].

LAZARUS, GS ;

ROCKLIN, RE ;

DAVID, JR ;

BUISSERE.JP ;

GOLDSMITH, LA ;

PINALS, RS ;

DRAPER, W .

ARCHIVES OF DERMATOLOGY, 1972, 105 (01) :46-+

[6]

MOSCHELLA SL, 2003, DERMATOLOGY, P415

[7]

MROWIETZ U, 2001, J CUTAN MED SURG, V5, P22

[8] PYODERMA GANGRENOSUM - ABNORMAL MONOCYTE FUNCTION CORRECTED INVITRO WITH HYDROCORTISONE [J].

NORRIS, DA ;

WESTON, WL ;

THORNE, EG ;

HUMBERT, JR .

ARCHIVES OF DERMATOLOGY, 1978, 114 (06) :906-911

[9] Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients [J].

Reichrath, J ;

Bens, G ;

Bonowitz, A ;

Tilgen, W .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) :273-283

[10] The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils [J].

Zuberbier, T ;

Chong, SU ;

Grunow, K ;

Guhl, S ;

Welker, P ;

Grassberger, M ;

Henz, BM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :275-280

← 1 →